A detailed history of Teacher Retirement System Of Texas transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 23,884 shares of VIR stock, worth $176,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,884
Previous 20,758 15.06%
Holding current value
$176,263
Previous $185,000 3.78%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.26 - $10.7 $22,694 - $33,448
3,126 Added 15.06%
23,884 $178,000
Q2 2024

Aug 09, 2024

SELL
$7.63 - $12.66 $1,541 - $2,557
-202 Reduced 0.96%
20,758 $185,000
Q1 2024

May 06, 2024

SELL
$8.6 - $11.9 $4,076 - $5,640
-474 Reduced 2.21%
20,960 $212,000
Q4 2023

Feb 07, 2024

SELL
$7.76 - $10.29 $25,654 - $34,018
-3,306 Reduced 13.36%
21,434 $216,000
Q3 2023

Oct 31, 2023

BUY
$9.14 - $24.62 $10,255 - $27,623
1,122 Added 4.75%
24,740 $232,000
Q2 2023

Jul 19, 2023

BUY
$23.2 - $27.29 $24,684 - $29,036
1,064 Added 4.72%
23,618 $579,000
Q1 2023

May 12, 2023

BUY
$22.26 - $30.85 $10,306 - $14,283
463 Added 2.1%
22,554 $525,000
Q4 2022

Feb 10, 2023

SELL
$19.96 - $28.22 $35,828 - $50,654
-1,795 Reduced 7.51%
22,091 $559,000
Q3 2022

Nov 03, 2022

BUY
$18.26 - $31.1 $226,204 - $385,266
12,388 Added 107.74%
23,886 $461,000
Q2 2022

Aug 09, 2022

SELL
$19.08 - $26.7 $36,919 - $51,664
-1,935 Reduced 14.4%
11,498 $293,000
Q1 2022

May 09, 2022

BUY
$21.19 - $40.01 $23,817 - $44,971
1,124 Added 9.13%
13,433 $345,000
Q4 2021

Feb 10, 2022

BUY
$30.97 - $54.03 $62,311 - $108,708
2,012 Added 19.54%
12,309 $515,000
Q3 2021

Nov 09, 2021

BUY
$34.9 - $54.54 $68,997 - $107,825
1,977 Added 23.76%
10,297 $448,000
Q2 2021

Aug 05, 2021

BUY
$38.75 - $51.0 $322,400 - $424,320
8,320 New
8,320 $393,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.